Neutral
Johnson & Johnson proposes $5.5 billion settlement to resolve talc lawsuits.
Johnson & Johnson has proposed a $5.5 billion settlement to resolve approximately 76,000 lawsuits alleging that its talc products caused ovarian cancer. The settlement is contingent upon at least 95% of the remaining claimants participating. The company plans to make an initial payment of up to $3 billion in 2027, with no further payments due until 2028.
Key points
- Shares of Johnson & Johnson rose more than 2% before the market opened following the settlement announcement.
- The proposed settlement aims to resolve a decade-long legal battle over talc-related lawsuits.
- Johnson & Johnson continues to maintain that its talc products are safe and do not contain asbestos.
Sources
AI-generated from public news sources. Not financial advice.
